Using the Beck Depression Inventory to Assess Anhedonia: A Scale Validation Study.

Ashby B Cogan, Jacqueline B Persons, Ann M Kring
Author Information
  1. Ashby B Cogan: University of California, Berkeley, USA. ORCID
  2. Jacqueline B Persons: University of California, Berkeley, USA.
  3. Ann M Kring: University of California, Berkeley, USA.

Abstract

Anhedonia is central to several psychological disorders and a frequent target of psychosocial and pharmacological treatments. We evaluated the psychometric properties of two widely used anhedonia measures derived from the Beck Depression Inventory: a 3-item (BDI-Anh3) and a 4-item version (BDI-Anh4). We evaluated these measures in a large undergraduate sample, a community sample, and a clinical sample. Both the BDI-Anh3 and the BDI-Anh4 showed adequate internal consistency, with BDI-Anh4 performing somewhat better, across the three samples. Both measures showed good convergent and discriminant validity, even after controlling for shared variance with other items on the BDI. These findings indicate that both measures have sufficient reliability and validity to support their use by researchers and clinicians.

Keywords

References

  1. J Affect Disord. 2019 Jan 15;243:188-192 [PMID: 30245249]
  2. J Pers Assess. 1996 Dec;67(3):588-97 [PMID: 8991972]
  3. Neuropsychopharmacology. 2015 Jun;40(7):1659-73 [PMID: 25578796]
  4. J Neural Transm (Vienna). 2012 Feb;119(2):253-60 [PMID: 21786117]
  5. Br J Psychiatry. 1995 Jul;167(1):99-103 [PMID: 7551619]
  6. Arch Gen Psychiatry. 1961 Jun;4:561-71 [PMID: 13688369]
  7. PLoS One. 2018 Mar 27;13(3):e0193619 [PMID: 29584785]
  8. Aust N Z J Psychiatry. 2014 Jan;48(1):36-51 [PMID: 24270310]
  9. Biol Psychiatry. 2006 Nov 15;60(10):1147-54 [PMID: 16806107]
  10. Arch Gen Psychiatry. 2012 Feb;69(2):139-49 [PMID: 21969419]
  11. Biol Psychiatry. 2008 Jun 1;63(11):1061-5 [PMID: 17976537]
  12. JAMA. 2021 Aug 17;326(7):621-627 [PMID: 34402850]
  13. Psychiatry Res. 2016 Dec 30;246:296-302 [PMID: 27744231]
  14. Arch Suicide Res. 2022 Apr-Jun;26(2):861-870 [PMID: 33135588]
  15. J Affect Disord. 2021 Nov 1;294:776-785 [PMID: 34375202]
  16. Psychiatry Res. 2010 Jun 30;178(1):205-7 [PMID: 20471106]
  17. Neuroimage. 2010 Feb 15;49(4):3276-85 [PMID: 19913621]
  18. J Nerv Ment Dis. 2022 Jul 1;210(7):497-503 [PMID: 35766543]
  19. Clin Psychol Sci. 2019 Nov;7(6):1190-1206 [PMID: 32042509]
  20. Omega (Westport). 2023 Sep;87(4):1280-1292 [PMID: 34344253]
  21. Psychol Med. 2012 May;42(5):967-80 [PMID: 21929846]
  22. Biol Psychiatry. 2005 Feb 15;57(4):319-27 [PMID: 15705346]
  23. Behav Res Ther. 1995 Mar;33(3):335-43 [PMID: 7726811]
  24. Sleep Disord. 2018 Jul 2;2018:1636574 [PMID: 30057824]
  25. Behav Res Methods. 2014 Dec;46(4):1023-31 [PMID: 24356996]
  26. Psychiatry Res. 2003 Aug 1;119(3):243-50 [PMID: 12914895]
  27. Biol Psychiatry. 2008 Jul 15;64(2):162-8 [PMID: 18242583]
  28. Arch Gen Psychiatry. 1983 Jan;40(1):79-84 [PMID: 6849623]
  29. J Pers Soc Psychol. 1988 Jun;54(6):1063-70 [PMID: 3397865]
  30. JAMA Psychiatry. 2019 Mar 1;76(3):324-335 [PMID: 30566197]
  31. J Psychiatr Res. 2019 Feb;109:202-213 [PMID: 30572276]
  32. Perspect Psychol Sci. 2018 Mar;13(2):149-154 [PMID: 29928846]
  33. J Abnorm Psychol. 1976 Aug;85(4):374-82 [PMID: 956504]
  34. Psychiatry Res. 2017 Dec;258:365-373 [PMID: 28888697]
  35. Psychol Med. 2008 Feb;38(2):289-300 [PMID: 17922940]
  36. Nat Rev Psychol. 2022 Jun;1(6):358-368 [PMID: 38107751]
  37. J Consult Clin Psychol. 1988 Dec;56(6):893-7 [PMID: 3204199]
  38. Psychophysiology. 2021 Apr;58(4):e13767 [PMID: 33433019]
  39. Psychiatry Res. 2014 Aug 15;218(1-2):124-8 [PMID: 24774075]
  40. Drug Alcohol Depend. 2015 Oct 1;155:202-7 [PMID: 26233484]
  41. Pers Individ Dif. 2007 Sep;43(4):725-735 [PMID: 18769508]
  42. J Pers Assess. 2011 May;93(3):213-24 [PMID: 21516580]
  43. PLoS One. 2019 Jun 21;14(6):e0217841 [PMID: 31226120]
  44. Neuropsychopharmacology. 2017 Mar;42(4):831-843 [PMID: 27585739]
  45. J Affect Disord. 2016 Oct;203:204-212 [PMID: 27295377]
  46. Front Psychiatry. 2013 Nov 25;4:152 [PMID: 24324445]
  47. Am J Psychiatry. 2009 Jun;166(6):702-10 [PMID: 19411368]
  48. Hum Brain Mapp. 2021 Feb 1;42(2):286-297 [PMID: 33030766]
  49. PLoS One. 2009 Aug 12;4(8):e6598 [PMID: 19672310]
  50. East Asian Arch Psychiatry. 2011 Sep;21(3):115-22 [PMID: 21921305]
  51. Psychol Well Being. 2011 Oct 24;1(1):1-3 [PMID: 22328976]
  52. J Affect Disord. 2017 Aug 15;218:195-200 [PMID: 28477497]
  53. Neuropsychopharmacology. 2015 Aug;40(9):2258-68 [PMID: 25767910]
  54. J Pers Soc Psychol. 2021 Aug;121(2):e1-e18 [PMID: 33119388]
  55. J Am Acad Child Adolesc Psychiatry. 2013 Jun;52(6):628-41.e13 [PMID: 23702452]
  56. J Am Acad Child Adolesc Psychiatry. 2012 Apr;51(4):404-11 [PMID: 22449646]
  57. Behav Res Ther. 2020 Feb;125:103507 [PMID: 31896529]
  58. Behav Res Ther. 2006 Mar;44(3):457-67 [PMID: 16446151]
  59. Psychol Assess. 2006 Mar;18(1):81-8 [PMID: 16594815]
  60. Behav Res Ther. 2009 May;47(5):374-81 [PMID: 19237152]
  61. Addict Behav. 2020 Mar;102:106183 [PMID: 31809878]
  62. Psychiatry Res. 2014 Jan 30;215(1):237-43 [PMID: 24210182]
  63. Psychol Rep. 2011 Jun;108(3):874-82 [PMID: 21879634]
  64. Int J Eat Disord. 2022 Feb;55(2):161-175 [PMID: 34811779]
  65. Schizophr Res. 2007 Jul;93(1-3):253-60 [PMID: 17490858]
  66. Depress Anxiety. 2018 May;35(5):382-392 [PMID: 29232491]
  67. Annu Rev Clin Psychol. 2013;9:409-33 [PMID: 23245340]
  68. Br J Clin Psychol. 2022 Jun;61(2):255-280 [PMID: 34625993]
  69. Psychol Assess. 2018 Sep;30(9):1237-1248 [PMID: 29620381]
  70. J Affect Disord. 2016 Oct;203:77-83 [PMID: 27280966]
  71. Eur Neuropsychopharmacol. 2014 May;24(5):725-36 [PMID: 24461724]
  72. J Subst Abuse Treat. 2018 Sep;92:46-50 [PMID: 30032944]
  73. J Clin Psychol. 2006 Dec;62(12):1545-58 [PMID: 17019674]
  74. Psychiatry Res. 2009 Apr 30;166(2-3):132-40 [PMID: 19272653]

MeSH Term

Humans
Depression
Anhedonia
Reproducibility of Results
Depressive Disorder
Psychiatric Status Rating Scales
Psychometrics

Word Cloud

Created with Highcharts 10.0.0measuresvalidityBeckDepressionBDI-Anh4sampleevaluatedanhedoniaBDI-Anh3showedinternalconsistencyconvergentdiscriminantBDIInventoryAnhedoniacentralseveralpsychologicaldisordersfrequenttargetpsychosocialpharmacologicaltreatmentspsychometricpropertiestwowidelyusedderivedInventory:3-item4-itemversionlargeundergraduatecommunityclinicaladequateperformingsomewhatbetteracrossthreesamplesgoodevencontrollingsharedvarianceitemsfindingsindicatesufficientreliabilitysupportuseresearcherscliniciansUsingAssessAnhedonia:ScaleValidationStudymeasurement-basedcarescalevalidation

Similar Articles

Cited By